191 related articles for article (PubMed ID: 36961799)
1. Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines.
Ustaszewski A; Paczkowska J; Janiszewska J; Bernhart SH; Bein J; Russiñol N; Hansmann ML; Chapaprieta V; Martín-Subero JI; Siebert R; Hartmann S; Giefing M
PLoS One; 2023; 18(3):e0283186. PubMed ID: 36961799
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
[TBL] [Abstract][Full Text] [Related]
3. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
[TBL] [Abstract][Full Text] [Related]
4. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
[TBL] [Abstract][Full Text] [Related]
5. Deregulated miRNAs Contribute to Silencing of B-Cell Specific Transcription Factors and Activation of NF-κB in Classical Hodgkin Lymphoma.
Paczkowska J; Janiszewska J; Ustaszewski A; Bein J; Skalski M; Dzikiewicz-Krawczyk A; Rozwadowska N; Hansmann ML; Hartmann S; Giefing M
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201504
[TBL] [Abstract][Full Text] [Related]
6. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
Schwering I; Bräuninger A; Distler V; Jesdinsky J; Diehl V; Hansmann ML; Rajewsky K; Küppers R
Mol Med; 2003; 9(3-4):85-95. PubMed ID: 12865944
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiling in classic Hodgkin lymphoma.
Navarro A; Gaya A; Martinez A; Urbano-Ispizua A; Pons A; Balagué O; Gel B; Abrisqueta P; Lopez-Guillermo A; Artells R; Montserrat E; Monzo M
Blood; 2008 Mar; 111(5):2825-32. PubMed ID: 18089852
[TBL] [Abstract][Full Text] [Related]
8. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.
Gibcus JH; Tan LP; Harms G; Schakel RN; de Jong D; Blokzijl T; Möller P; Poppema S; Kroesen BJ; van den Berg A
Neoplasia; 2009 Feb; 11(2):167-76. PubMed ID: 19177201
[TBL] [Abstract][Full Text] [Related]
10. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.
Xie L; Ushmorov A; Leithäuser F; Guan H; Steidl C; Färbinger J; Pelzer C; Vogel MJ; Maier HJ; Gascoyne RD; Möller P; Wirth T
Blood; 2012 Apr; 119(15):3503-11. PubMed ID: 22343918
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.
Sánchez-Espiridión B; Martín-Moreno AM; Montalbán C; Figueroa V; Vega F; Younes A; Medeiros LJ; Alvés FJ; Canales M; Estévez M; Menarguez J; Sabín P; Ruiz-Marcellán MC; Lopez A; Sánchez-Godoy P; Burgos F; Santonja C; López JL; Piris MA; Garcia JF
Br J Haematol; 2013 Aug; 162(3):336-47. PubMed ID: 23725219
[TBL] [Abstract][Full Text] [Related]
12. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma.
Santisteban-Espejo A; Bernal-Florindo I; Montero-Pavon P; Perez-Requena J; Atienza-Cuevas L; Fernandez-Valle MDC; Villalba-Fernandez A; Garcia-Rojo M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473705
[TBL] [Abstract][Full Text] [Related]
14. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
Tian X; Xu J; Dorfman DM
Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
[TBL] [Abstract][Full Text] [Related]
15. Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.
Natkunam Y; Hsi ED; Aoun P; Zhao S; Elson P; Pohlman B; Naushad H; Bast M; Levy R; Lossos IS
Blood; 2007 Jan; 109(1):298-305. PubMed ID: 16954503
[TBL] [Abstract][Full Text] [Related]
16. Differentiating germinal center-derived lymphomas through their cellular microenvironment.
Carbone A; Gloghini A; Cabras A; Elia G
Am J Hematol; 2009 Jul; 84(7):435-8. PubMed ID: 19484731
[TBL] [Abstract][Full Text] [Related]
17. Surfaceome of classical Hodgkin and non-Hodgkin lymphoma.
Hofmann A; Thiesler T; Gerrits B; Behnke S; Sobotzki N; Omasits U; Bausch-Fluck D; Bock T; Aebersold R; Moch H; Tinguely M; Wollscheid B
Proteomics Clin Appl; 2015 Aug; 9(7-8):661-70. PubMed ID: 26076441
[TBL] [Abstract][Full Text] [Related]
18. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
[TBL] [Abstract][Full Text] [Related]
19. Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation.
Osswald CD; Xie L; Guan H; Herrmann F; Pick SM; Vogel MJ; Gehringer F; Chan FC; Steidl C; Wirth T; Ushmorov A
Blood; 2018 Apr; 131(14):1556-1567. PubMed ID: 29439954
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.
Giefing M; Winoto-Morbach S; Sosna J; Döring C; Klapper W; Küppers R; Böttcher S; Adam D; Siebert R; Schütze S
PLoS One; 2013; 8(12):e84928. PubMed ID: 24376854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
